The association between plasma proteomics and incident cardiovascular disease identifies MMP-12 as a promising cardiovascular risk marker in patients with chronic kidney disease
Open Access
- 1 August 2020
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 307, 11-15
Abstract
No abstract availableKeywords
Funding Information
- Hjärt-Lungfonden
- Vetenskapsrådet
This publication has 27 references indexed in Scilit:
- A Novel MMP12 Locus Is Associated with Large Artery Atherosclerotic Stroke Using a Genome-Wide Age-at-Onset Informed ApproachPLOS Genetics, 2014
- Left Ventricular Systolic Dysfunction in Outpatients with Peripheral Atherosclerotic Vascular Disease: Prevalence and Association with Location of Arterial DiseaseEuropean Journal of Heart Failure, 2014
- Homogenous 96-Plex PEA Immunoassay Exhibiting High Sensitivity, Specificity, and Excellent ScalabilityPLOS ONE, 2014
- Analysis of a Urinary Biomarker Panel for Incident Kidney Disease and Clinical OutcomesJournal of the American Society of Nephrology, 2013
- Matrix metalloproteinases in kidney homeostasis and diseasesAmerican Journal of Physiology-Renal Physiology, 2012
- Searching for New Biomarkers of Renal Diseases through ProteomicsClinical Chemistry, 2012
- Homogeneous antibody-based proximity extension assays provide sensitive and specific detection of low-abundant proteins in human bloodNucleic Acids Research, 2011
- Urinary proteomics as a novel tool for biomarker discovery in kidney diseasesJournal of Zhejiang University-SCIENCE B, 2010
- Matrix metalloproteinase-2 and -9 exacerbate arterial stiffening and angiogenesis in diabetes and chronic kidney diseaseCardiovascular Research, 2009
- Arterial compliance and endothelium-dependent vasodilation are independently related to coronary risk in the elderly: the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) studyClinical Physiology and Functional Imaging, 2008